Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
Author(s) -
Antonin Lévy,
C. FaivreFinn
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.04.45
Subject(s) - radiation therapy , stage (stratigraphy) , lung cancer , medicine , oncology , cancer , biology , paleontology
Department of Radiation Oncology, Institut d’Oncologie Thoracique (IOT), Gustave Roussy, Villejuif, France; Univ Paris Sud, Université ParisSaclay, Le Kremlin-Bicêtre, France; INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, The Christie NHS Foundation Trust, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK Correspondence to: Antonin Levy, MD, PhD. Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France. Email: Antonin.LEVY@gustaveroussy.fr. Provenance and Peer Review: This article was commissioned and reviewed by the Section Editor Dr. Chun-Ru Chien (Director, Department of Radiation Oncology, China Medical University Hsinchu Hospital, Hsinchu; Professor, Department of Radiation Oncology, China Medical University, Taichung). Comment on: Hu X, Bao Y, Xu Y, et al. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses. Cancer 2020;126:840-9.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom